New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice
Authors
Keywords
-
Journal
Therapeutic Advances in Chronic Disease
Volume 9, Issue 3, Pages 77-87
Publisher
SAGE Publications
Online
2017-12-14
DOI
10.1177/2040622317743486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
- (2017) Peter Nash et al. LANCET
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
- (2016) Jürgen Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis: Table 1
- (2016) Mira Merashli et al. ANNALS OF THE RHEUMATIC DISEASES
- A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis
- (2016) Katelijne De Wilde et al. ANNALS OF THE RHEUMATIC DISEASES
- Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
- (2016) Christopher J Edwards et al. ANNALS OF THE RHEUMATIC DISEASES
- An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series
- (2016) G Varkas et al. ANNALS OF THE RHEUMATIC DISEASES
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of secukinumab in the treatment of psoriasis
- (2016) Andrew Blauvelt Expert Opinion On Drug Safety
- Sacroiliac joint radiographic progression — speed and determinants
- (2016) Victoria Navarro-Compán et al. Nature Reviews Rheumatology
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
- (2016) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ankylosing Spondylitis and Axial Spondyloarthritis
- (2016) Joel D. Taurog et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics
- (2016) Louise Hamilton et al. RHEUMATOLOGY
- Exercise for ankylosing spondylitis: An evidence-based consensus statement
- (2016) Janet R. Millner et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- 'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease
- (2015) Dennis McGonagle et al. Nature Reviews Rheumatology
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
- (2015) J. Sieper et al. Arthritis & Rheumatology
- American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
- (2015) Michael M. Ward et al. Arthritis & Rheumatology
- Vaccines and biologics: Table 1
- (2014) Isabel Ferreira et al. ANNALS OF THE RHEUMATIC DISEASES
- Age at symptom onset in ankylosing spondylitis: is there a gender difference?
- (2014) Adrian Ciurea et al. ANNALS OF THE RHEUMATIC DISEASES
- Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
- (2014) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort
- (2014) D. Wallis et al. RHEUMATOLOGY
- Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
- (2014) Maxime Dougados et al. Arthritis & Rheumatology
- Editorial: Animal Models of Spondyloarthritis: Do They Faithfully Mirror Human Disease?
- (2014) Maxime Breban et al. Arthritis & Rheumatology
- Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
- (2013) R Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
- (2013) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
- (2012) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms?
- (2012) Nigil Haroon et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis
- (2012) Féline Kroon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis
- (2012) Ejaz Pathan et al. ANNALS OF THE RHEUMATIC DISEASES
- Review: Nonradiographic axial spondyloarthritis: New definition of an old disease?
- (2012) Joachim Sieper et al. ARTHRITIS AND RHEUMATISM
- Secukinumab failure in Crohn's disease: the yeast connection?
- (2012) Jean Frédéric Colombel et al. GUT
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
- (2011) I.-H. Song et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2010) S. van Assen et al. ANNALS OF THE RHEUMATIC DISEASES
- Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial
- (2010) I.-H. Song et al. ARTHRITIS AND RHEUMATISM
- BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
- (2010) T. Ding et al. RHEUMATOLOGY
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
- (2009) M Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
- (2009) J Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- The joint–gut axis in inflammatory bowel diseases
- (2009) Lianne K.P.M. Brakenhoff et al. Journal of Crohns & Colitis
- Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years
- (2008) A. N. Bennett et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial
- (2008) Robert D. Inman et al. ARTHRITIS AND RHEUMATISM
- Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis
- (2008) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search